<--- Back to Details
First PageDocument Content
Viral diseases / Viruses / Hepatitis / Viral hepatitis / Hepatitis B / Hepatitis C / Hepatitis A / Infection / Interferon / Medicine / Health / Biology
Date: 2013-05-08 05:35:22
Viral diseases
Viruses
Hepatitis
Viral hepatitis
Hepatitis B
Hepatitis C
Hepatitis A
Infection
Interferon
Medicine
Health
Biology

Microsoft Word - B133_1Add2-en.docx

Add to Reading List

Source URL: apps.who.int

Download Document from Source Website

File Size: 31,13 KB

Share Document on Facebook

Similar Documents

PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C  New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno

DocID: 1vlwz - View Document

IMPORTANT PLEASE READ PART III: CONSUMER INFORMATION INTRON A® interferon alfa-2b This leaflet is part III of a three-part "Product Monograph"

DocID: 1uNBi - View Document

Evaluation of Interferon-gamma-Producing T Cells

DocID: 1uFKZ - View Document

PRODUCT MONOGRAPH INTRON A® interferon alfa-2b Lyophilized Powder with Diluent: 10 million IU interferon alfa-2b/vial

DocID: 1umTG - View Document

  Data Sheet Recombinant Human Interferon-gamma (rh IFN-) Preclinical Grade - Order No.: µg)

DocID: 1u1rK - View Document